Human papillomavirus (HPV) 16 is involved in causing cervical cancer. The E6 and E7 proteins of HPV 16 immortalize human keratinocytes and this is due, at least in part, to inactivation of the tumor suppressor proteins p53 and pRB. These tumor suppressor proteins also regulate the expression of pro-and antiangiogenic factors by cells. For this reason, experiments were conducted to determine whether the expression of E6 and E7 in primary keratinocytes alters the phenotype of these cells such that they express diminished levels of antiangiogenic factors and/or increased levels of proangiogenic factors. To avoid variances in experimental observations, pools of human foreskin keratinocytes from multiple sources were infected with recombinant retrovirus expressing HPV 16 E6 and E7 or control retrovirus. Gene array analysis, RT-PCR, ELISAs and Western blotting showed that in cells expressing HPV 16 E6 and E7, expression levels of two potent angiogenesis inhibitors, thrombospondin-1 and maspin, were lower compared to controls. Additionally, major angiogenesis inducers, interleukin-8 and vascular endothelial growth factor (VEGF), were increased relative to controls. VEGF can be produced as multiple splice variants, all of which are required for the formation of patent blood vessels. The expression of HPV 16 E6 and E7 in keratinocytes augmented expression of VEGF 121, 145, 165 and 189. These observations show that HPV 16 E6 and E7 alter the phenotype of primary keratinocytes, diminishing expression of inhibitors and increasing expression of inducers of angiogenesis. This altered phenotype may permit keratinocytes infected by HPV 16 to play a role in the progression of cancer by permitting tumors to acquire a blood supply permissive of growth and spread.
Introduction
Human papillomaviruses (HPVs) are small doublestranded DNA viruses that infect keratinocytes, causing a wide range of hyperproliferative diseases. Based on their propensity to cause cancer, these viruses are classified as high risk (e.g. HPV 16, 18 and 31) or low risk (e.g. HPV 6/11) (Munger and Howley, 2002) . Infection by low-risk virus leads to development of benign lesions, while infection by high-risk virus may lead to development of cervical carcinomas. Following infection by high-risk virus, the E6 and E7 genes are consistently expressed, initially at low levels and then at higher levels either upon cellular differentiation (Grassmann et al., 1996) or upon integration of the viral genome during progression to cervical cancer (Jeon and Lambert, 1995) . Transformation occurs over an extended period of time, with expression of both the E6 and E7 proteins being necessary for maintenance of the malignant phenotype (von Knebel et al., 1992; Hu et al., 1995) . Although both E6 and E7 can immortalize cells individually, simultaneous expression of both genes results in enhanced immortalization (Halbert et al., 1991; Wazer et al., 1995) . Furthermore, while both genes are able to immortalize cells, their expression is not sufficient for development of solid tumors. Introduction of an activated ras gene results in these cells becoming tumorigenic (Matlashewski et al., 1987; Rhim et al., 1998) .
The development of solid tumors is a multistep process, which requires the collaboration of several key steps (Hanahan and Weinberg, 2000) . One critical feature that must be acquired by transformed cells is the ability to recruit a blood supply from existing vasculature, a process known as angiogenesis (Folkman and Shing, 1992; Bouck et al., 1996) . This process enables a developing tumor to acquire nutrients and oxygen that sustain growth and expansion. Regulation of angiogenesis is tightly controlled. The existing evidence suggests that on a local level, the balance of angiogenic inhibitors versus angiogenic inducers produced by tumor cells or virally infected cells in the process of becoming tumors determines whether or not the surrounding endothelium remains quiescent or is activated .
In tumor cells, a link between the function of tumor suppressors and regulation of angiogenesis has been shown. Several studies have indicated that loss of tumor suppressors in tumors can lead to an altered phenotype in which the activities of angiogenic inducers increase relative to the activities of angiogenic inhibitors (Igarashi et al., 2002; Gomez-Manzano et al., 2003) . This phenotypic change is called the angiogenic switch, a consequence of which is that transformed cells initiate the process of tumor neovascularization. The angiogenic switch results from diminished expression of inhibitors of angiogenesis, augmented expression of inducers of angiogenesis or both of these changes by tumor cells (Vikhanskaya et al., 2001) .
When HPV 16 infects keratinocytes, one major function of E6 and E7 is to disrupt the activity of two tumor suppressor proteins, p53 and pRB. This disruption results in deregulated proliferation and unrestricted cell cycle entry (Munger and Howley, 2002) . Previous studies that examined angiogenesis in cervical cancer have demonstrated that angiogenesis is an early event that becomes evident before malignancy. In both, a transgenic mouse model expressing HPV 16 early genes, and in human cervical lesions progressing along the continuum from low-grade dysplasia to invasive carcinoma, data indicate that angiogenesis occurs in a stepwise manner. Increasing vascular density and increasing expression of the proangiogenic factor vascular endothelial growth factor (VEGF) correlates with progression toward tumor development (Arbeit et al., 1994; Guidi et al., 1995; Smith-McCune et al., 1997) . Although it has been suggested that the HPV proteins contribute to this angiogenic switch, the direct contribution of HPV proteins to this process was not assessed since these experiments are conducted long after the initial infection and other cellular changes have occurred as well.
While it is known that expressing HPV 16 E6 and E7 proteins in primary cells is able to immortalize but not transform them, it is not known whether these cells have yet to undergo an angiogenic switch in which the level of inhibitors of angiogenesis has diminished and/or inducers of angiogenesis has increased. Prior to such a change, infected keratinocytes would lack the ability to activate adjacent endothelium and undergo neovascularization permissive of tumor growth. The experiments in this study focused on changes induced by HPV in early passage primary human keratinocytes. We tested whether the E6 and E7 proteins of HPV 16 have the capacity to alter the expression of pro-and antiangiogenic factors. The results show that expression of HPV 16 E6 and E7, in primary foreskin keratinocytes is sufficient to alter the profile of expression of angiogenic factors and therefore adds a new type of activity to the repertoire of functions previously described for these viral proteins.
Results
Expression of HPV 16 E6 and E7 in pooled human foreskin keratinocytes results in decreased levels of pRB and p53
Pooled foreskin keratinocytes were infected with recombinant retrovirus expressing HPV 16 E6 and E7 proteins, L(16E6E7)SN, or with a control parental retrovirus, LXSN. To detect expression of HPV 16 mRNA, Northern blot analysis was conducted using a probe specific for HPV 16 E6E7 transcripts. A transcript was detected in cells infected with L(16E6E7)SN, verifying expression of the HPV cDNA, and no transcript was detected in LXSN or mock-infected cells (Figure 1a) .
It is well documented in the literature that expression of HPV 16 E6 results in degradation of p53, while expression of HPV 16 E7 results in degradation of pRB (Scheffner et al., 1990; Boyer et al., 1996; Gonzalez et al., 2001) . Thus, to determine if the expressed E6 and E7 proteins were functioning as expected, Western blot analysis was performed on whole-cell lysates of the infected cells. In cells infected with L(16E6E7)SN, there was a decrease in both p53 (Figure 1b ) and pRB protein levels ( Figure 1c ). These results demonstrate that the expressed HPV 16 E7 and E6 proteins are functioning as expected.
Expression of HPV 16 E6 and E7 in pooled human foreskin keratinocytes modulates p53-regulated angiogenic genes
We next examined the capacity of keratinocytes to express factors that could subsequently promote or inhibit angiogenesis. This was accomplished by expressing HPV 16 E6 and E7 in keratinocytes, isolating RNA and then using focused microarray analysis to analyse gene expression. The array contained 96 genes that play a role in modulating the angiogenic process, including transcription factors, adhesion molecules, cytokines, matrix proteins, protease inhibitors and growth factors. The expression of HPV 16 E6 and E7 induced changes in several genes that modulate angiogenesis ( Figure 2 , Table 1 ). Among these genes were three regulated by p53. Expression of both thrombospondin-1 and maspin, inhibitors of angiogenesis, has been shown to be positively regulated by p53, whereas expression of VEGF, an inducer of angiogenesis, has been shown to be negatively regulated by p53 via the HIF-1 alpha transcription factor (Ravi et al., 2000; Zou et al., 2000; Harada et al., 2003) . On the microarray membranes, levels of thrombospondin-1 and maspin were decreased, while levels of VEGF were increased in cells expressing HPV 16 E6 and E7.
Verification of microarray analysis
To verify the results obtained from microarray analysis, semiquantitative limiting cycle RT-PCR was performed. In cells expressing HPV 16 E6 and E7, RNA levels of both thrombospondin-1 ( Figure 3a ) and maspin ( Figure 4a ) were lower than the levels in mock-infected and LXSN-infected cells, as shown at 18 and 22 cycles, while levels of VEGF increased ( Figure 5a ).
Secretion of thrombospondin-1 ( Figure 3b ) and maspin ( Figure 4b ) into the supernatant of infected cells was analysed by Western blot analysis. In cells expressing HPV 16 E6 and E7, levels of both proteins decreased more than twofold compared to controls. Ponceau S staining of the nitrocellulose membrane indicated equal loading of total protein (data not shown). ELISAs indicated that the secreted levels of VEGF in supernatants from cells expressing HPV 16 E6 and E7 were increased 3-4-fold compared to mockinfected or LXSN-infected cells (Figure 5b ).
Transient expression of HPV 16 E6 downregulates maspin promoter activity
Maspin is a p53 target gene (Zou et al., 2000) . Consequently, downregulation of p53 would be predicted to diminish maspin promoter activity. To test this, foreskin keratinocytes were cotransfected with either control plasmid, pSV, or plasmid expressing HPV 16 E6, pSV16E6 and a plasmid containing the luciferase gene under control of the maspin promoter (maspin-luciferase). In cells cotransfected with maspinluciferase and pSV16E6, luciferase activity was downregulated to about 40% of that in control cells, cotransfected with pSV and maspin-luciferase ( Figure 4c ).
Expression of HPV 16 E6 and E7 in pooled human foreskin keratinocytes increases interleukin-8 secretion
Interleukin-8 (IL-8) is a cytokine that is involved in inflammation, chemotaxis and growth promotion (Hoffmann et al., 2002) . IL-8 is often upregulated upon viral infection as well as during wound healing (Gillitzer and Goebeler, 2001 ). More recently, IL-8 has been implicated as the major inducer of tumor angiogenesis in oral squamous cell carcinomas (Lingen et al., 1996) . We therefore determined the level of secreted IL-8 in keratinocytes when HPV 16 E6 and E7 were expressed. The expression of HPV 16 E6 and E7 increased the secretion of IL-8 approximately 2-3-fold relative to control-infected cells. This increase in IL-8 secretion continued over several passages in culture ( Figure 6 ).
Discussion
Deregulation of the functions of tumor suppressor proteins, p53 and pRB, plays a critical role in transforming cells following infection by HPV 16. While such infection disrupts cell cycle progression, this alone is not sufficient for tumorigenesis (Furumoto and Irahara, 2002) . The ability of tumor cells to appropriate a blood supply from the host is essential to aggressive growth and spread. Neovascularization requires tumor cells to undergo a phenotypic change called the 'angiogenic switch'. A result of the angiogenic switch is that tumor cells express diminished levels of inhibitors of angiogenesis, augmented levels of promoters of angiogenesis or both processes may occur. A consequence of the angiogenic switch is that tumor cells may acquire a blood supply from the host (Hanahan and Folkman, 1996) . The goal of the present study was to determine whether expression of HPV 16 E6 and E7 in keratinocytes not only results in immortalization of these cells but also alters the pattern of gene expression by these cells such that they would have undergone a Figure 1 (a) Detection of HPV 16E6E7 expression in keratinocytes. Total RNA (10 mg) from mock-infected, control (LXSN) and L(16E6E7)SN-infected keratinocytes was separated by electrophoresis on a 1% formaldehyde agarose gel and transferred onto a nylon membrane. The blot was probed with [a-32 ]dATP HPV 16 E6 and E7 DNA. The blot was then stripped and reprobed with a GAPDH-specific probe to demonstrate equal loading in all the lanes. This experiment is representative of three independent infections of two different pools of keratinocytes. (b, c) Western blot analysis. Whole-cell lysate (50 mg) from mock-infected, LXSN or L(16E6E7)SN infected keratinocytes was separated on a 12% polyacrylamide gel. The proteins were transferred to nitrocellulose and probed with antibodies to p53 (b) and pRB (c). The blot was stripped and reprobed with antibody to GAPDH to verify equal loading change through which they might ultimately undergo neovascularization. The demonstration that active expression of HPV gene products in primary keratinocytes could affect such a change would provide an insight into yet another mechanism through which this virus could promote malignancies.
We therefore tested whether expression of both E6 and E7 in keratinocytes is sufficient to alter expression of genes already demonstrated to activate quiescent endothelium adjacent to tumors. Changes in the levels of angiogenic factors as a result of HPV 16 E6 and E7 expression by recombinant retrovirus were examined early after infection of primary keratinocytes, while control cells are still proliferating. Both RNA analysis (Table 1, Figures 2-5 ) and protein analysis (Figures 3-6) showed that HPV 16 E6 and E7 altered the keratinocyte gene expression in favor of factors that have been shown to promote angiogenesis Hanahan and Folkman, 1996) . In our model system, expression of the antiangiogenic factors thrombospondin-1 and maspin decreased in HPV 16 E6 and E7 expressing keratinocytes but not in mock-infected cells. The expression of VEGF and IL-8, both potent inducers of angiogenesis, increased in HPV 16 E6 and E7 expressing keratinocytes, but not in controls. Figure 2 MicroArray analysis of angiogenesis-modulating genes. Total RNA (5 mg) from infected keratinocytes was reversed transcribed. The cDNA was then hybridized to a nylon membrane containing 96 angiogenesis-related genes. The signals from housekeeping genes b-actin and GAPDH were used to normalize for differences in exposure between the two blots, and the relative expression of specific genes was determined Supernatants from cultured infected cells were concentrated using centriplus concentrators. Total protein (25 mg) was separated on a 12% SDS-PAGE gel and transferred onto a nitrocellulose membrane. The blot was stained with Ponceau S to verify equal loading (not shown). The blot was probed using antibody to thrombspondin-1 (tsp-1)
There are multiple isoforms of VEGF, only some of which, VEGF 121 and VEGF 165 , are secreted (Leung et al., 1989; Ferrara et al., 1991; Houck et al., 1991; Charnock-Jones et al., 1993) . RT-PCR analysis documented that elevated levels of spliced transcripts encoding all isoforms of VEGF are made (Figure 5a ), and ELISAs verified that elevated levels of secreted VEGF isoforms are produced in the cells expressing HPV 16 E6 and E7 (Figure 5b) . The results reported here suggest that HPV 16 E6 and E7 expression in keratinocytes renders these cells capable of producing the entire complement of VEGF isoforms associated with angiogenesis, as is seen in HPV disease.
Our ELISA results demonstrate that IL-8 is upregulated following expression of HPV 16 E6 and E7 (Figure 6 ). The regulation of IL-8 expression is Western blot analysis for secreted maspin. Supernatants from cultured infected cells were concentrated using centriplus concentrators. In all, 25 mg of total protein was separated on a 12% SDS-PAGE gel and transferred onto a nitrocellulose membrane. The blot was stained with Ponceau S to verify equal loading (not shown). The blot was probed using antibody to maspin. (c) Transient transfection of human keratinocytes with maspin promoter. Human foreskin keratinocytes were transfected with 1 mg of reporter DNA (maspin-luciferase), and 4 mg of effector DNA (pSV or pSV16E6). After 48 h, cells were harvested. As a control for transfection efficiency, the cells were cotransfected with a plasmid encoding b-galactosidase. Luciferase activity was normalized to b-galactosidase readings and the luciferase units in vector control cells were set to 100%. The results shown are an average of three independent experiments with standard deviations displayed Figure 5 (a) Limiting cycle RT-PCR analysis. Total RNA (1 mg) from infected or mock-infected keratinocytes was reversed transcribed and the cDNA amplified by PCR using primers specific for VEGF. The primers used recognize four isoforms of VEGF (Kodama et al., 1999) . The reactions were stopped after 18 and 22 cycles and product was visualized on a 1% EtBr stained agarose gel. controlled at the transcriptional as well as at posttranscriptional levels (Hoffmann et al., 2002) . The IL-8 promoter contains binding sites for three inducible transcription factors, NFkB, AP-1 and C/EBP, which, depending upon cell type and stimulus, cooperate to regulate IL-8 expression (Hoffmann et al., 2002) . Potentially relevant to the IL-8 promoter, E7 binds and augments AP-1 activity, while E6 transactivates through the NFkB responsive element (Desaintes et al., 1992; Antinore et al., 1996) . Nees et al. (2001) reported that, following retroviral expression of HPV 16 E6 and E7, IL-8 secretion, as determined by ELISA, was upregulated, possibly through NFkB activation. In contrast, Huang and McCance (2002) recently reported that cotransfection of keratinocytes with either HPV 16 E6 or E7 and a plasmid expressing luciferase from the IL-8 promoter resulted in decreased expression of luciferase through the IL-8 NFkB site. The difference in outcome of these two sets of experiments may relate to differences in analysing endogenous genes versus transiently introduced promoters regulating reporter genes.
M (mock-infected cells), L (LXSN-infected cells) and 16 (L(16E6E7)SN-infected cells
HPV oncoproteins E6 and E7 disrupt the functions of tumor suppressors p53 and pRB, respectively. Three of the factors whose levels are altered in HPV 16 E6 and E7 expressing cells are regulated by p53. Loss of p53 results in upregulation of VEGF (Ravi et al., 2000) , and downregulation of thrombospondin-1 (Kieser et al., 1994; Mukhopadhyay et al., 1995; Dawson et al., 1999) and maspin (Zou et al., 2000) . Other studies show that adding p53 to cell lines that were in a proangiogenic state resulted in a reversion to an antiangiogenic phenotype (Volpert et al., 1997) . While it is reasonable to speculate that targeting of p53 for degradation by E6 can account for the changes in expression levels of the factors that we have observed, other mechanisms are possible. The regulation of thrombospondin-1 via p53 seems to be cell type and tumor type specific (Bouck, 1996; Cinatl Jr, et al., 1999) . The regulation of VEGF by E6 can occur via a p53-independent mechanism. In p53À/À mouse embryonic fibroblast cells, E6 transactivated the VEGF promoter via Sp-1 transcription factor binding sites . The VEGF promoter also contains an AP-1 site that could potentially be activated by E7 (Tischer et al., 1991; Antinore et al., 1996) .
The effects of HPV 16 E6 and E7 on early passage primary human foreskin keratinocytes that are described above, recapitulate those observed in a transgenic HPV mouse model, HPV-positive human lesions and long-term cultures of cervical carcinoma cells. For example, analysis of both the HPV 16 early region transgenic mouse model and human biopsies indicates that induction of angiogenesis is an early event, occurring in the premalignant stages. Such angiogenesis correlates with an increase in the level of VEGF mRNA and protein (Guidi et al., 1995; Dobbs et al., 1997; Smith-McCune et al., 1997) . Decreased levels of thrombospondin-1 mRNA have been reported in invasive cervical cancer (Kodama et al., 2001) and elevated levels of IL-8 have been detected in cervical secretions of women with cervical cancers (Tjiong et al., 1999) . A study by Bequet-Romero and Lopez-Ocejo (2000) showed a decreased level of thrombospondin-1 and increased levels of VEGF and IL-8 in cervical cancer cell lines containing HPV. Thus, our observations with primary keratinocytes expressing HPV 16 E6 and E7 recapitulate aspects of the progression of cervical cancer in animal models and humans and provide a new and powerful means of dissecting molecular events associated with this process.
Angiogenesis is regulated locally by a balance of secreted factors (Folkman and Shing, 1992; Bouck et al., 1996) . As a cell progresses to tumorigenicity, the balance of the levels of inducers and inhibitors is switched, so that angiogenic inducers become the predominantly secreted factors, relative to angiogenic inhibitors. Our results suggest that HPV 16 E6 and E7 oncoproteins may contribute to the development of cervical cancer not only by disrupting cell cycle regulation but also by creating a microenvironment that fosters the growth of tumors.
Materials and methods

Cell culture
Primary human foreskin keratinocytes were prepared from newborn foreskins as described (Rheinwald, 1980) . Briefly, keratinocytes from an individual foreskin were seeded into three 10-cm plates containing a layer of mitomycin C-treated 3T3-J2 fibroblasts. The cells were grown in E media containing 10% fetal calf serum, 0.4 mg/ml hydrocortisone, 0.1 nM cholera toxin, 5 mg/ml transferrin, 2 nM 3,3 0 -5-triodo-L-thyronine, 5 ng/ ml epidermal growth factor and 1 Â antibiotic-antimycotic solution (100 U penicillin/ml, 0.1 mg/ml streptomycin and 0.25 mg/ml amphotericin B). At B85% confluence, the cultures were trypsinized, expanded once and frozen as stocks at À801C. To make pooled keratinocyte cultures, one vial of frozen foreskin keratinocytes was thawed and plated in SFM. After reaching B85% confluency, the cells were trypsinized, counted and an equal number of cells from foreskin of 6-8 individuals were mixed. Two nonoverlapping pools of foreskin keratinocytes were frozen for subsequent use in this study.
Retroviral infection
Two aliquots from one pool of keratinocytes and one aliquot from a second pool of keratinocytes were thawed and plated in SFM in 10-cm dishes. The cells were mock infected or infected with 5 ml of recombinant retrovirus L(16E6E7)SN, expressing the E6 and E7 oncoproteins of HPV 16, or parental virus LXSN as a control and 8 mg polybrene/ml. After 6 h the culture media was aspirated, fresh SFM was added and incubation continued for 48 h. The cells were then split 1 : 4 onto 10-cm dishes and selected with 200 mg/ml G418 for 3-4 days. After selection, the cells were expanded and used for experiments between passages 4 and 6. Similar magnitudes of difference were observed with all three infections.
ELISA analysis
IL-8 secretion was quantitated in supernatants using the Quantikine Duo-set ELISA kit from R&D systems. Briefly, supernatants from confluent cells were collected, treated with protease inhibitors and centrifuged to remove cell debris. Samples and standards (200 ml/well) were added to ELISA plates coated with IL-8 antibodies and incubated overnight at 41C with agitation. After incubation, the plate was processed according to the manufacturer's protocol. The results are reported as pg of IL-8/mg of total protein in supernatants. VEGF was similarly quantitated.
Protein extraction and immunoblot analysis
For analysis of p53, pRB and GAPDH, whole-cell extracts were made by lysing cells with 2 Â lysis buffer (20% glycerol, 4% sodium dodecyl sulfate (SDS) and 120 mM Tris-HCl (pH 6.8)). The lysate was boiled for 10 min, centrifuged at 14 000 r.p.m. to pellet cellular debris and stored at À801C. Protein concentrations were determined using the Bio-Rad DC protein assay kit. For analysis of secreted thrombospondin-1 and maspin, supernatants were collected from the cells and concentrated using centriplus concentrators (Amicon, Beverly, MA, USA). Protein concentration was determined using the Biorad protein assay. A total of 25 mg of total protein was separated on 12% SDS polyacrylamide gels. Western blot analysis was performed following standard protocol (Ai et al., 1999) . Primary antibodies were used at a 1 : 1000 dilution: (p53 (DO-1 Santa Cruz), pRB (Pharmingen), GAPDH (Chemicon), thrombospondin-1 (Oncogene) and maspin (Pharmingen)). Secondary goat anti-mouse antiserum (Bio-Rad) was diluted 1 : 3000 into Tris-buffered saline þ 0.1% Tween-20 (TBS-t) containing 5% nonfat dry milk. The Biorad Immun-star chemiluminescent protein detection system was used to visualize proteins.
RNA isolation
Monolayers of cells were grown to B90% confluence in SFM and total RNA was isolated using the RNeasy Minikit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. Contaminating DNA was removed during isolation by digestion using the RNase-Free DNase Set (Qiagen, Valencia, CA, USA). Quantitated RNA was then stored at À801C.
Northern blot analysis
A total of 10 mg of total RNA was separated on a 1% agarose formaldehyde gel and transferred onto a nylon membrane (Hybond N þ ). A 32 P-labeled gel purified DNA fragment containing the HPV 16 E6 and E7 sequence was used to probe for E6 and E7 mRNA expression. The blots were hybridized in ExpressHyb (Clontech) at 681 and processed according to the manufacturer's instructions. Bound probe was visualized by autoradiography. The blot was stripped and exposed to a probe for GAPDH to determine loading efficiency.
Microarray analysis
GEArray Q Series MicroArray (SuperArray, Frederick, MD, USA) was used according to the manufacturer's protocol. Total RNA from pooled HFKs was isolated and DNAse treated as described above. In total, 5 mg of RNA was labeled and hybridized to the membrane. The membranes were exposed to film and changes in gene expression were determined after normalizing to the signal intensity of control, housekeeping genes, b-actin and GAPDH.
Semiquantitative limiting cycle RT-PCR analysis
Superscript Onestep RT-PCR kit (Invitrogen) was used to amplify 1 mg of RNA from mock-, LXSN-or L(16E6E7)SNinfected cells. Amplification was stopped at 18 and 22 cycles and the products were visualized by EtBr staining on a 1% agarose gel. The following primers and conditions were used: maspin-forward TGCGTATGCCACCAACTTACA; reverse CGGCTATTGTGAGAATCCCTG annealing temperature 501C; thrombospondin-1 forward AATGGACTGTTGAT AGCTCGACTGA; reverse TGGACAGGCATCCATCAA TTGGACA annealing temperature 551C; GAPDH forward GAAGGTGAAGGTCGGAGTCA; reverse GAAGATGGT-GATGGGATTTC annealing temperature 551C; and VEGF forward CGAAGTGGTGAAGTTCATGGTG; reverse TTCTGTATCAGTCTTTCCTGGTGAG annealing temperature 551C.
Transient transfections
Foreskin keratinocytes (1.2 Â 10 5 cells/well) were plated into 12-well plates in 2 ml of SFM and incubated overnight. The following day, the cells were transfected using polybrene (Pattison et al., 1997) . In all, 1 mg of maspin-luciferase DNA, and 4 mg of pSV or pSV16E6 DNA were added per well. Cells were harvested after 48 h. As a control for transfection efficiency, the cells were cotransfected with a plasmid encoding b-galactosidase expressed from the CMV promoter. Luciferase activity was normalized to b-galactosidase readings to control for variances of transfection efficiency.
